Clinical Trial Update: : Protescal: Prevention of Hypertrophic Scar and Keloid Formation Post Caesarean Section [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Protescal investigating prevention of hypertrophic scar and keloid formation after Caesarean section, completed phase 2 and phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Caesarean Wound
• Hypertrophic Surgical Scar
• Keloid Scar Following Surgery

Drugs mentioned

• Protescal

Snippet

Sponsor: Universiti Kebangsaan Malaysia Medical Centre | Conditions: Caesarean Wound, Hypertrophic Surgical Scar | Phase 2, Phase 3 | Status: COMPLETED